A US National Institute of Allergy and Infectious Diseases-led team sequenced the exome of a young girl with recurrent, severe infections to uncover the gene variant.
NIH researchers got tantalizingly close to long-term engraftment at levels that could provide a clinical benefit in gene therapy applications.
There are a number of efforts underway to develop DNA vaccines for diseases like Zika, according to the Wall Street Journal.
The agency has committed $11 million for the creation of a network of research centers that will use systems biology approaches to build predictive models for infectious diseases.
The National Institute of Allergy and Infectious Diseases is seeking proposals for research into the three-dimensional atomic structures of pathogen proteins.
The researchers will use a new humanized mouse model to obtain genetic information at different life stages of the parasite.
Researchers put together an almost 2-billion-base genome assembly for the deer tick, which can transmit pathogens causing Lyme disease and other conditions.
An autosomal dominant form of vibratory urticaria has been linked to a missense mutation in the ADGRE2 gene that appears to affect mast cell function and inflammation.
A National Institutes of Health team demonstrated EBOV RNA can be found in semen using strategies approved for finding the virus in blood.
The partners will develop a multiplexed nucleic acid-based assay to detect carbapenem-resistant Enterobacteriaceae from whole blood samples.
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.